Stock Events

Stock Events

CannPal Animal Therapeutics Limited 

A$0.170000
2
+A$0.01+6.25% Thursday 05:20

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

19AugExpected
Q3 2017
Q4 2017
Q2 2018
Q4 2018
Q2 2019
Q4 2019
Q2 2020
-0.02
-0.01
-0.01
0
Expected EPS
0
Actual EPS
-0.01

Financials

-Profit Margin
Unprofitable
2016
2018
2019
2020
0Revenue
-1.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CP1.AU. It's not an investment recommendation.
Bendigo and Adelaide Bank
2
BEN.AU
Aurizon Limited
2
AZJ.AU
Duxton Farms
2
DBF.AU
CZR Resources
2
CZR.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Phibro Animal Health
PAHC
Mkt Cap1.3B
Phibro Animal Health Corporation produces animal health and nutritional products for pets, competing in the same industry as CannPal.
Idexx Laboratories
IDXX
Mkt Cap44.46B
IDEXX Laboratories, Inc. offers diagnostic and healthcare products for pets, overlapping with CannPal's market in animal health.
Zoetis
ZTS
Mkt Cap31.68B
Zoetis Inc. is a global leader in animal health pharmaceuticals and vaccines, serving the same target market as CannPal.
Elanco Animal Health
ELAN
Mkt Cap12.4B
Elanco Animal Health Incorporated provides products and services for animal health, competing in the same space as CannPal.
Abeona Therapeutics
ABEO
Mkt Cap397.83M
Abeona Therapeutics Inc. works on developing gene and cell therapies, including applications in veterinary medicine.

About

CannPal Animal Therapeutics Limited, an animal health company, engages in the research and development of plant-based therapeutic products for pets in Australia. It develops CPAT-01, a cannabis-derived pharmaceutical product to provide veterinarians and pet owners to treat pain and inflammation in dogs. The company was incorporated in 2016 and is based in Double Bay, Australia. As of March 11, 2021, CannPal Animal Therapeutics Limited operates as a subsidiary of AusCann Group Holdings Ltd.
Show more...
CEO
Mr. Layton Patrick Mills
Country
Australia
ISIN
AU000000CP17

Listings

STU
DE
41C.STU
AU
AU
CP1.AU

0 Comments

Share your thoughts

FAQ

What is CannPal Animal Therapeutics Limited stock price today?▼
The current price of CP1.AU is A$0.17 AUD — it has increased by +6.25% in the past 24 hours. Watch CannPal Animal Therapeutics Limited stock price performance more closely on the chart.
What is CannPal Animal Therapeutics Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange CannPal Animal Therapeutics Limited stocks are traded under the ticker CP1.AU.
What were CannPal Animal Therapeutics Limited earnings last quarter?▼
CP1.AU earnings for the last quarter are -0.01 AUD per share, whereas the estimation was 0 AUD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is CannPal Animal Therapeutics Limited revenue for the last year?▼
CannPal Animal Therapeutics Limited revenue for the last year amounts to 0 AUD.
What is CannPal Animal Therapeutics Limited net income for the last year?▼
CP1.AU net income for the last year is -1.7M AUD.
In which sector is CannPal Animal Therapeutics Limited located?▼
CannPal Animal Therapeutics Limited operates in the Health & Wellness sector.
When did CannPal Animal Therapeutics Limited complete a stock split?▼
CannPal Animal Therapeutics Limited has not had any recent stock splits.
Where is CannPal Animal Therapeutics Limited headquartered?▼
CannPal Animal Therapeutics Limited is headquartered in Double Bay, Australia.